Condition
Cancer Gene Mutation
Total Trials
5
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting3
Unknown2
Clinical Trials (5)
Showing 5 of 5 trials
NCT07498829Not ApplicableRecruiting
Population Based Germline Testing for Early Detection and Prevention of Cancer
NCT05126290RecruitingPrimary
CTNNA1 Familial Expansion Study
NCT06008392Recruiting
INTERogating Cancer for Etiology, Prevention and Therapy Navigation
NCT04759352Not ApplicableUnknownPrimary
Telephone Versus In-person Post-test Cancer Genetic Counseling
NCT04516083UnknownPrimary
Lynch Syndrome Can be Diagnosed Just From Somatic Mismatch Repair Mutation
Showing all 5 trials